Stock screener

XERS

Conviction 74HealthcareScan · Thu, Sep 24, 2026
Bullish engulfing

Xeris Biopharma Holdings, Inc. (XERS) closed at $8.95 (+3.35%) on Sep 24, 2026. Its latest daily candle is a bullish engulfing. Price is above its 50-day and above its 200-day moving average. RSI(14) 63, RS Rating 85, -9.6% from its 52-week high, +21.8% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

XERS$8.95+3.35%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 2.21M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Xeris Biopharma Holdings, Inc.PHARMACEUTICAL PREPARATIONSwww.xerispharma.com ↗
Price8.95
Change+3.35%
Gap-0.92%
Rel volume1.14×
Avg volume1.94M
Avg $ vol15.96M
SMA 208.27
SMA 508.35
SMA 2007.12
Price vs 50+7.12%
Price vs 200+25.64%
MA stackbullish
50/200 cross—
Supertrendup · 7.64
RSI (14)63
MACD hist0.11
MACD crossbull · 3d
Stoch %K / %D86 / 80
ADX (14)20
+DI / −DI29 / 15
RSI divergence—
MACD divergence—
ATR %4.52%
ADR %4.66%
52w high9.90
52w low5.29
From 52w high-9.60%
Above 52w low+69.19%
New 52w highNo
SqueezeOff
Bollinger width22.51%
%B0.87
Donchian pos86.11%
Donchian high9.20
Donchian low7.40
AVWAP (52w high)7.19
vs AVWAP high+24.43%
AVWAP (52w low)7.33
vs AVWAP low+22.14%
OBV trendFlat
Chaikin MF (20)0.11
Today vs 20d1.14×
Avg vol (14d)2.21M
Avg vol (20d)1.94M
Avg $ vol (20d)15.96M
Market cap1.63B
RS Rating85 / 99
RS 3m (vs SPY)+16.45%
RS 6m (vs SPY)+52.05%
RS line new highNo
Trend template6/8
Technical rank91.9
1 week+9.68%
1 month+2.40%
3 months+20.95%
6 months+68.87%
1 year+13.15%
YTD+21.77%
P/E2945.43
P/B-167.64
P/S5.59
P/FCF59.25
EPS0.0000
Div yield—
ROE-5.69%
ROA0.13%
Debt/Eq-25.95
Current1.45
EV/EBITDA67.25
Gross margin—
Net margin0.19%
Rev growth43.72%
EPS growth101.01%
Price target12.67
Target upside41.56%
Analyst ratingBuy
Institutional66.13%
Ent. value1.76B
Revenue92.1M
Net income-31.1M
Gross profit7.84M
Free cash flow27.54M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out172.64M
Employees435
ListedThu, Jun 21, 2018
Free float153.98M
Float %92.8%
Short interest8.04M
Days to cover5.5d
Short volume37.3%
Squeeze score38 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.00 vs $0.02
Last surprise-100.0% miss
Setup gradeB
Conviction74 / 100
Pattern quality—
Tech rank91.9 / 100
Group rank59 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBullish engulfing

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in XERS

All disclosures →
No recent disclosed trades by Congress in XERS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in XERS · open-market 5 sells

InsiderSideShares
McCulloch Kevin
See Remarks · Common Stock · 2026-08-01
Tax21.92K
Shannon John Patrick Jr
See Remarks · Common Stock · 2026-08-01
Tax36.65K
Pieper Steven
See Remarks · Common Stock · 2026-08-12
Sell5K
Pieper Steven
See Remarks · Common Stock · 2026-07-07
Sell27.6K
Pieper Steven
See Remarks · Common Stock · 2026-07-06
Sell17.4K
Kong Garheng
Director · Common Stock · 2026-06-04
Grant24.19K
BORMANN-KENNEDY BARBARA-JEAN ANNE
Director · Common Stock · 2026-06-04
Sell16K
BORMANN-KENNEDY BARBARA-JEAN ANNE
Director · Common Stock · 2026-06-04
Grant24.19K
HALKUFF DAWN
Director · Common Stock · 2026-06-04
Sell20K
HALKUFF DAWN
Director · Common Stock · 2026-06-04
Grant24.19K

SEC filings

EDGAR filings in XERS · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.